Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Tim Schlidt
Recent news which mentions Tim Schlidt
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance
November 07, 2022
Tickers
ATAI
CMPS
DRUG
MSSTF
Tags
CMPS
Small Cap
Palo Santo
From
Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Public Market Valuations & Private Investment
November 02, 2022
Tags
Benzinga
Tim Schlidt
Palo Santo
From
Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities
October 31, 2022
Tickers
ATAI
CMPS
Tags
Small Cap
CMPS
Palo Santo
From
Benzinga
Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More
October 14, 2022
Tickers
CMPS
PSIL
PSYK
TSLA
Tags
Psychedelic/Assisted Therapies
Small Cap
CMPS
From
Benzinga
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund
October 12, 2022
Tags
Cosmo Feilding Mellen
Palo Santo
Multidisciplinary Association for Psychedelic Studies
From
Benzinga
Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCann
February 14, 2022
Tickers
AAWH
CLVR
MMNFF
NCNNF
Tags
General
Small Cap
executives
From
Benzinga
Cannabis Movers & Shakers: Synendos Therapeutics, Rapid Therapeutic Science Laboratories, Palo Santo, Avicanna
November 10, 2021
Tickers
AVCNF
RTSL
Tags
Movers & Shakers
AVCNF
Cannabis
From
Benzinga
$35M VC fund in Chicago is backing startups using psychedelics in health care
July 15, 2021
Tickers
INNO
Tags
Inno
David Sherman
Chicago Blackhawks
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.